Alimera repays $15 million pSivida note

April 28, 2010 by MassDevice staff

Alimera Sciences Inc.'s IPO last week triggers the payment of a $15 million note plus interest to pSivida Corp.

PSDV logo

pSivida Corp. (NSDQ:PSDV) reeled a $15.3 million payment from Alimera Sciences Inc. (NSDQ:ALIM) triggered by Alimera's April 21 initial public offering.

The two companies are collaborating on a drug-device combination called Iluvien, designed to treat diabetic macular edema. Last week Alimera raised $72 million in its IPO, selling 6.6 million shares at $11 each.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.